Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Research and Development of Medical Consumables and Devices	95.27M	53.53M	40.95M	27.15M	22.43M
Research and Development of Medical Consumables and Devices Growth	77.97%	30.72%	50.83%	21.06%	147.69%
Total	95.27M	53.53M	40.95M	27.15M	22.43M
Total Growth	77.97%	30.72%	50.83%	21.06%	147.69%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Mainland China	95.27M	53.53M	40.95M	27.15M	22.43M
Mainland China Growth	77.97%	30.72%	50.83%	21.06%	147.69%
Total	95.27M	53.53M	40.95M	27.15M	22.43M
Total Growth	77.97%	30.72%	50.83%	21.06%	147.69%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 10, 2026

Data Sources Report a data error